A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Recruiting · NCT07047690 · Registry updated 2026-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, interstitial lung disease, limited cutaneous systemic sclerosis, lung disorder, respiratory system disorder, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-03-31 | NCT07047690 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Galderma R&D | 23 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||